Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

Relationship between the Series named OTC Products and Pharmacist's Professional Workloads in Community Pharmacy

지역약사의 시리즈형 OTC 약물에 대한 약사의 직능 수행에 대한 평가

  • Kim, Jeong Eun (Lab of clinical Pharmacy, College of Pharmacy, The Catholic University of Korea) ;
  • Lim, Sung Cil (Lab of clinical Pharmacy, College of Pharmacy, The Catholic University of Korea)
  • 김정은 (가톨릭대학교 약학대학 임상약학 연구실) ;
  • 임성실 (가톨릭대학교 약학대학 임상약학 연구실)
  • Received : 2020.05.23
  • Accepted : 2020.10.04
  • Published : 2020.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Currently, the over-the-counter (OTC) drug market is flooded with series OTC products. The pharmacist must follow the OTC product's indication, given that the most critical role of a pharmacist is the right selection and recommendation of an OTC drug for a patient's symptoms in a dynamic pharmacy environment. Therefore, pharmacists must know each OTC product information precisely to avoid any ambiguity due to several OTC series brand names. Objective: We evaluated the risk and effectiveness of OTC series medicines. Methods: From December 5 to December 18, 2019, an online survey was conducted among 145 community pharmacists. Results: A total of 51.0% of pharmacists knew the difference between products named in a series and could explain it spontaneously. Only 0.7% of the pharmacists admitted to not knowing the difference between products named in a series. While 42.9% of pharmacists who owned a pharmacy opined that the OTC medicines named in a series have health benefits for patients, 50.0% of employee pharmacists admitted that they were rather confused because there are several OTC series medicines. In contrast, 69.2% of pharmacists who owned pharmacies and 72.2% of employee pharmacists admitted that OTC series drugs with names similar to popular OTC drugs sell better. Conclusion: While pharmacists had different opinions regarding OTC series drugs per employment status, they opined that OTC series are more helpful in pharmacy management than completely new brand names. Further studies in this regard are needed.

Keywords

References

  1. Korea Law Information Center. Pharmaceutical affairs Act No. 14328, Chapter I, Article 2-9. Dec 02, 2016. Enforced, Dec 02, 2016. Partial Amendment. Available from https://www.law.go.kr/LSW/lsInfoP.do?lsiSeq=125346#0000. Accessed December 05, 2020.
  2. Hong JR. A Study on the newspaper advertising of medicines in Korea-an analysis of the contents that major brands advertise in daily newspapers. M.S. Thesis for Business Administration Dongguk University. 1990.
  3. Levien TL. International drug name confusion. Hosp Pharm 2006;41(7):697-700. https://doi.org/10.1310/hpj4107-697
  4. Rados C. Drug name confusion: Preventing medication errors health experts work to minimize the potential for confusion between products with names that look or sound alike. FDA consumer 2005;39(4):35-7.
  5. Kim EG, Hwang JH, Kim CY, Oh BH. A Study on nurses' perception and experience of medication error. The Seoul Journal of Nursing 1998;12(1):133-50.
  6. Kang SM. Analysis of perception for medication errors in community pharmacy. M.S Thesis for pharmacy Sungkyun Kwan University. 2017.
  7. Ministry of Food and Drug Safety of Republic of Korea. Ministry of Food and Drug Safety Notification No. 2018-95, Regulation for Pharmaceutical Approvals, Notifications and Reviews, Chapter II, Article 10-3. Nov 27, 2018. Partially Amended and Enforced. Available from https://www.mfds.go.kr/brd/m_211/view.do?seq=11961&srchFr=&srchTo=&srchWord=%EC%9D%98%EC%95%BD%ED%92%88%EC%9D%98+%ED%92%88%EB%AA%A9%ED%97%88%EA%B0%80+%EC%8B%A0%EA%B3%A0+%EC%8B%AC%EC%82%AC+%EA%B7%9C%EC%A0%95&srchTp=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&Data_stts_gubun=C9999&page=1. Accessed December 05, 2020.
  8. National Institute of Food and Drug Safety Evaluation of Republic of Korea, Drug Review Management Division.: Casebook of product name given to medicine (drug) authorization and reporting, Nov, 2018 Available from http://www.nifds.go.kr/brd/m_15/view.do?seq=12610. Accessed December 05, 2020.
  9. IQVIA, 30-Top-selling Over-the-counter drugs in Korea, the first half of 2018. Available from https://news.v.daum.net/v/20180822133544741. Accessed July 31, 2020.
  10. Kim JE, Lim SC. Analysis on the consumer behavior and perception of similar nomenclature of series named nonprescription drugs. Yakhak Hoeji 2020;64(4):265-72. https://doi.org/10.17480/psk.2020.64.4.265
  11. Ministry of Food and Drug Safety of Republic of Korea. Pharmaceutical Management Division.: Number of OTC & prescription drugs and production amount-by year: 2009-2018. Available from https://www.mfds.go.kr/wpge/m_314/de010603l0001.do. Accessed July 31, 2020.